Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells

Currently, there is no appropriate treatment option for patients with sorafenib-resistant hepatocellular carcinoma (HCC). Meanwhile, pronounced anticancer activities of newly-developed mitochondria-accumulating self-assembly peptides (Mito-FF) have been demonstrated. This study intended to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Tae Ho, Jeena, M. T., Kim, Ok-Hee, Kim, Kee-Hwan, Choi, Ho Joong, Lee, Kyung Hee, Hong, Ha-Eun, Ryu, Ja-Hyoung, Kim, Say-June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806888/
https://www.ncbi.nlm.nih.gov/pubmed/33441650
http://dx.doi.org/10.1038/s41598-020-79536-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806888/
https://www.ncbi.nlm.nih.gov/pubmed/33441650
http://dx.doi.org/10.1038/s41598-020-79536-z

Ejemplares similares